Covid-19 vaccine has better immune response with two full-dose regime, claims Oxford

Oxford University on Thursday said that its COVID-19 vaccine candidate has a better immune response when a two full-dose regime is used rather than a full-dose followed by a half-dose booster, Reuters reported. Oxford's vaccine candidate, licensed to AstraZeneca, has published interim late stage trial results showing higher efficacy when a half dose is followed by a full dose, compared to a two full-dose regime, though more work needs to be done to affirm the result.

Oxford University on Thursday said that its COVID-19 vaccine candidate has a better immune response when a two full-dose regime is used rather than a full-dose followed by a half-dose booster, Reuters reported. Oxford's vaccine candidate, licensed to AstraZeneca, has published interim late stage trial results showing higher efficacy when a half dose is followed by a full dose, compared to a two full-dose regime, though more work needs to be done to affirm the result. December 18, 2020 at 09:00AM https://ift.tt/2KkskxO